MRI Analysis of Glycosaminoglycan Modifications Inside the Intervertebral Disk After Distraction and Posterior Fusion
NCT02815696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-02-06
Summary
Degenerative disc disease (DDD) is the primary cause of low back pain. The most important factor in the development of DDD is the vertical load force on the disc, increasing the hydrostatic pressure and facilitating discs degenerations. One of the most common conditions accompanying DDD is segmental instability of the spine. The pathogenesis evolves in three phases characterized by a progressive disc dehydration and loss of the disc height.
This phenomenon can be observed in magnetic resonance imaging (T2 weighted MRI) as a decrease of the water signal inside the intervertebral disc. It is considered as an indirect sign of the alteration of the composition (including glycosaminoglycans) and the structure of the intervertebral disk with, as consequence, a modification of the spine biomechanics. Animal studies showed that disc regeneration could be enhanced by a decrease of the hydrostatic pressure. This could be observed as a signal increase on T2 weighted MRI.
Recent quantitative MRI sequences now allow the quantification of glycosaminoglycans (GAG) concentration inside the cartilage and in the intervertebral disc.
The actual surgical trends are in favor of an anterior (intersomatic) vertebrak fusion, associated or not with a posterior fusion. These technics sacrifice the intervertebral disc and change the spine biomechanics.
Based on a pilot study, the investigators believe that the conservation and even a regeneration of the intervertebral disc is possible and allows the preservation of the spine biomechanics.
The purpose of the study is to analyze the relations between specific MRI signals, the GAGs concentration, and the functional outcome before and after the surgical treatment.
Conditions
- Lumbar Spine Instability
Interventions
- DEVICE
-
Magnetic Resonance Imaging
Specific MRI sequences (delayed gadolinium-enhanced magnetic resonance imaging of cartilage -dGEMRIC) performed before the surgery, 6 months and 1 year after surgery will allow to measure the following parameters: disc height, total lumbar spine lenght, GAGs concentration.
Sponsors & Collaborators
-
Brugmann University Hospital
lead OTHER
Principal Investigators
-
Tamas Illes, MD · CHU Brugmann
-
Dinh Qui Du PHAN, MD · CHU Brugmann
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-01
- Primary Completion
- 2024-06-16
- Completion
- 2024-06-16
Countries
- Belgium
Study Locations
More Related Trials
-
Lumbar Intervertebral Disc Herniation
NCT02110186 ·Status: UNKNOWN ·Phase: NA
-
Lumbar Disc Space Height in Young Disc Herniation and Degeneration Patients
NCT02351206 ·Status: COMPLETED
-
Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis
NCT06797700 ·Status: NOT_YET_RECRUITING
-
The Role of Disc Nutrition in the Etiology and Clinical Treatment of Disc Degeneration
NCT04134910 ·Status: WITHDRAWN ·Phase: NA
-
Predictability of the Effects of Facet Joint Infiltration in the Degenerate Lumbar Spine When Assessing MRI Scans
NCT03308149 ·Status: COMPLETED
-
A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration
NCT01124006 ·Status: COMPLETED ·Phase: PHASE2
-
Percutaneous Dynamic Stabilization (PDS) System Versus Fusion for Treating Degenerative Disc Disease
NCT00878579 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of IDD Therapy and Non-surgical Treatment for Low Back Pain Caused by Degenerative Disc Disease
NCT00165893 ·Status: COMPLETED ·Phase: PHASE4
-
Interbody Systems: Post Market Clinical Follow-up Study
NCT04911257 ·Status: TERMINATED
-
Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® Disc Augmentation System: A Pilot Study
NCT00693784 ·Status: COMPLETED ·Phase: NA
-
Study On Discopathie With Modic 1
NCT03303261 ·Status: TERMINATED
-
Treatment of Discogenic Back Pain
NCT02089139 ·Status: TERMINATED ·Phase: NA
-
Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NCT03100032 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back Pain
NCT02587637 ·Status: COMPLETED ·Phase: NA
-
Multimodal Bio-mechanical Analysis of Adult Spinal Deformity With Sagittal Plane Misalignment
NCT04812730 ·Status: RECRUITING ·Phase: NA
-
Understanding Non-Response in Spine Fusion Surgery
NCT02611479 ·Status: COMPLETED
-
Large Array EMG Discriminability in Discogenic Low Back Pain
NCT00220948 ·Status: UNKNOWN ·Phase: NA
-
MR Elastography for the Herniated Intervertebral Disc
NCT03340545 ·Status: COMPLETED ·Phase: NA
-
Intradiscal rhGDF-5 Phase I/II Clinical Trial
NCT00813813 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Pivotal Study of rhBMP-2/ACS/INTER FIX™ Device for Posterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
NCT01491464 ·Status: TERMINATED ·Phase: NA
-
Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease
NCT01799616 ·Status: UNKNOWN ·Phase: PHASE2
-
Paraspinal Muscle Remodeling
NCT03753711 ·Status: COMPLETED ·Phase: NA
-
Lumbar Fusion or Non-operative Care for Treatment of Presumed Discogenic Pain
NCT02695576 ·Status: COMPLETED ·Phase: NA
-
Identification of Biomarkers and Molecular Targets Involved on Intervertebral Disc Degeneration and Discogenic Pain
NCT06349226 ·Status: RECRUITING
-
Tissue Collection for Understanding Intervertebral Disc Degeneration and Back Pain
NCT01633034 ·Status: ACTIVE_NOT_RECRUITING